October 31, 2017
UPCOMING /Recent Talks

Dr. Carl June's CAR-T Cell Journey and the Cancer Treatment Revolution

with Dr. Carl June 
November 15th, 2017. 1PM EST RSVP
FDA approval of the breakthrough CAR-T cell therapy for cancer brings the first approved gene therapy treatment to the United States. It reprograms the body's own immune system to recognise and kill cancer cells. The therapy initially called CAR-T cell immunotherapy and now named Kymriah by Novartis, is approved to treat children and young adults with a recurrent form of the blood cancer called acute lymphoblastic leukemia (ALL). Dr. Carl June of University of Pennsylvania is one of the pioneers of CAR-T cell research and leads the team responsible for the historic FDA approval. We are discussing Dr. June's CAR-T cell journey to understand the nuances of this new therapy. The discussion will also bring to focus the opportunity that these engineered immune cells present to cancer treatment, and their possible use in treatment of other cancers. 
Panelists
Dr. Carl June
Gary Petersen
Jack Aiello 
Mike Scott 
Priya Menon
Demystifying Stem Cell Transplants for Multiple Myeloma Treatment 
with Dr. Rafael Fonseca
October 4th, 2017. 5 PM EST LISTEN
In 2017 stem cell transplants remains a key option for treatment of eligible multiple myeloma patients, and in majority pf patients its is done as a part of frontline therapy. Research shows that stem cell transplants significantly increase the amount of time, for which a patient has their disease under control. How safe are these transplants? Who is eligible to get one? What are the side effects and how can patients tackle them? The myeloma panel is talking to Dr. Rafael Fonseca for answers to these and more on the latest developments in stem cell transplant technology in multiple myeloma.   
Panelists
Dr. Rafael Fonseca 
Gary Petersen 
Jack Aiello
Yelak Beru 
Priya Menon 
CureTalks Webinar: Climbing Mount Kilimanjaro for the Multiple Myeloma Research Foundation with Matt Goldman
September 26th, 2017. 6PM EST LISTEN
In February 2017, along with 5 other patients and 10 individuals who have had their lives impacted by myeloma, Matt Goldman climbed Mt. Kilimanjaro in Tanzania, Africa. They were raising funds for multiple myeloma research foundation (MMRF), which is a leading organisation working to find myeloma cure. Kilimanjaro is 19,000 feet high. The journey took 8 days where they covered over 40 miles. Join us to hear Matt re-live his experience. 


Panelists
Matt Goldman 
Shweta Mishra 
For any of the talks dial-in to 718-664-6574 to participate and ask a question LIVE On-Air! Only 50 callers permitted at one time so HURRY!
Our Picks